Thermo Fisher Scientific Inc
NYSE:TMO:US
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of mid-2022 (revenue figures include some cross-segment revenue): analytical technologies (15% of sales); specialty diagnostic products (10%); life science solutions (30%); and lab products and services, which includes CRO services (51%).
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.Â